Indications for: EBANGA
Infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection.
Limitations of Use:
Not established for other species of the Ebolavirus and Marburgvirus genera.
Adults and Children:
See full labeling. Give 50mg/kg as a single IV infusion over 60mins.
Monitor for hypersensitivity reactions including infusion-associated events. Discontinue immediately and treat if severe or life-threatening hypersensitivity reactions occur. Pregnancy (do not withhold treatment). Nursing mothers.
Human IgG1 monoclonal antibody.
Avoid concomitant live vaccines.
Pyrexia, tachycardia, diarrhea, vomiting, hypotension, tachypnea, chills.
Generic Drug Availability:
Single-dose vials—1, 4, 8, 36